Scientists hunt for hidden genetic causes of rare bleeding disorder

NCT ID NCT07674381

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study investigates inherited thrombocytopenias, rare conditions where low platelet counts cause bleeding problems. About half of patients have an unknown genetic cause. Researchers aim to identify new disease genes and build a lab-grown bone marrow model to test how well drugs like Eltrombopag might work for each person. The goal is to improve diagnosis and personalize future treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could uncover new genetic forms of inherited thrombocytopenias and enable personalized treatment predictions.

What could go wrong

This is an observational and laboratory-based study, not a treatment trial. Findings may not translate into immediate clinical benefits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INHERITED THROMBOCYTOPENIAS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

inherited thrombocytopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Medicina Generale 1, Fondazione IRCCS Policlinico San Matteo

    Pavia, 27100, Italy